Jim Cramer on Pfizer: “The Drug Stocks Are Just in a World of Hurt, and This One Continues to Be There”

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently talked about. During the lightning round, when a caller asked about the stock, Cramer commented:

“I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to change it. But right now, the drug stocks are just in a world of hurt, and this one continues to be there. You can own it. They gotta figure out something. That yield will protect you for a while, though.”

Pfizer Inc. (NYSE:PFE) researches, develops, and manufactures biopharmaceutical products and vaccines. Cramer discussed it during the September 22 episode of Squawk on the Street. He said:

“Pfizer is being viewed as a company that doesn’t really have anything. Meaning that people feel that the Seagen acquisition didn’t pay off. That was a very big acquisition. I don’t wanna write them off, but it’s kind of like cholesterol. . .where you finally just, you know you got a number of players in it, and everybody did well. I think that can happen here.”

While we acknowledge the risk and potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.